mirtazapine has been researched along with Thoracic Neoplasms in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kinomura, M | 1 |
Iihara, H | 1 |
Fujii, H | 1 |
Hirose, C | 1 |
Endo, J | 1 |
Yanase, K | 1 |
Inui, T | 1 |
Kaito, D | 1 |
Sasaki, Y | 1 |
Gomyo, T | 1 |
Sakai-Masuda, C | 1 |
Kawae, D | 1 |
Kitamura, YU | 1 |
Fukui, M | 1 |
Kobayashi, R | 1 |
Ohno, Y | 1 |
Suzuki, A | 1 |
1 other study available for mirtazapine and Thoracic Neoplasms
Article | Year |
---|---|
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
Topics: Antiemetics; Carboplatin; Humans; Mirtazapine; Nausea; Platinum; Retrospective Studies; Serotonin; T | 2023 |